Improving predictability of generic product bioequivalence in pediatric populations by using advanced dissolution apparatus in conjunction with PBPK modelling for high risk oral products

Activity: Talk or presentation typesInvited talk

Description

FDA 2024 Generic Drug Science and Research Initiatives Public Workshop
Period21 May 2024
Held atFood and Drug Administration (USA) FDA, United States